On ECHEMI
Home > Drugs > Shandong Luye Pharmaceutical Co., Ltd.

Shandong Luye Pharmaceutical Co., Ltd.

  • Founded in:

    1994-06-08
  • Country:

    China China
  • Address:

    No. 15, Chuangye Road, High-tech Zone, Yantai City, Shandong Province
  • Tax NO.:

    913706001650849788
  • Registered Funds:

    2,031.8 million yuan
  • Website:

  • Email:

Related Drugs
Compound Sodium Aescinate Gel
This product is a compound preparation, each 1g contains 10mg of sodium aescinate and 50mg of diethylamine salicylate.
Name Description Content CAS NO. Registered Holders
Escin, monosodium salt

Anti-tissue edema, promote blood circulation, reduce vascular permeability, prevent water accumulation in tissues and eliminate the heaviness and pressure caused by local edema

More

Anti-tissue edema, promote blood circulation, reduce vascular permeability, prevent water accumulation in tissues and eliminate the heaviness and pressure caused by local edema

10mg 20977-05-3 7
DIETHYLAMINE SALICYLATE

Enhances anti-inflammatory effects and has analgesic effects

More

Enhances anti-inflammatory effects and has analgesic effects

50mg 4419-92-5 3
Ximingting tablets
Total saponins of Cimicifuga.
Name Description Content CAS NO. Registered Holders
Total saponins of Cimicifuga

0
Sodium Glycididazole for Injection
The main ingredient of this product is sodium glycidazole.
Name Description Content CAS NO. Registered Holders
Sodium glycididazole

Sodium glycidibizole is a sensitizer for tumor radiotherapy. It belongs to the nitroimidazole class of compounds and can fix the damage caused by radiation to the DNA of tumor hypoxic cells and inhibit the repair of DNA damage, thereby increasing the sensitivity of tumor hypoxic cells to radiation.

More

Sodium glycidibizole is a sensitizer for tumor radiotherapy. It belongs to the nitroimidazole class of compounds and can fix the damage caused by radiation to the DNA of tumor hypoxic cells and inhibit the repair of DNA damage, thereby increasing the sensitivity of tumor hypoxic cells to radiation.

173357-17-0 1
Sodium Glycididazole for Injection
The main ingredient of this product is sodium glycidazole.
Name Description Content CAS NO. Registered Holders
Sodium glycididazole

Sodium glycidibizole is a sensitizer for tumor radiotherapy. It belongs to the nitroimidazole class of compounds and can fix the damage caused by radiation to the DNA of tumor hypoxic cells and inhibit the repair of DNA damage, thereby increasing the sensitivity of tumor hypoxic cells to radiation.

More

Sodium glycidibizole is a sensitizer for tumor radiotherapy. It belongs to the nitroimidazole class of compounds and can fix the damage caused by radiation to the DNA of tumor hypoxic cells and inhibit the repair of DNA damage, thereby increasing the sensitivity of tumor hypoxic cells to radiation.

173357-17-0 1
Sodium Glycididazole
Name Description Content CAS NO. Registered Holders
Sodium glycididazole

Not clearly described

More

Not clearly described

173357-17-0 1
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.